Alzheimer's disease is a devastating neurological disorder characterized by progressive memory loss and cognitive deficits. To date, four genes have been found to be associated with Alzheimer's disease phenotypes including the amyloid precursor protein gene on chromosome 21 (1-4), the apolipoprotein E gene on chromosome 19 (5-7), the presenilin-1 (PS-1) 1 gene on chromosome 14 (8), and the presenilin-2 (PS-2) gene on chromosome 1 (9, 10). The majority of familial Alzheimer's disease cases are associated with over 40 independent mutations in the PS-1 genes of unrelated families that all display an early-ageof-onset Alzheimer's phenotype (8,(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25). Although the current literature suggests that intracellular PS-1 is intimately associated with the ␥-secretase activity that facilitates amyloid- peptide release (26), the precise function of PS-1 proteins found in the synaptic membranes remains elusive and is also a matter of active investigation. Human PS-1 is widely expressed in a variety of organs throughout the body (8). This distribution raises the question as to why mutations in the PS-1 gene and its products appear to confer a disease state that selectively affects the brains of patients with familial Alzheimer's disease without apparent effect on their peripheral organs. In contrast, rat PS-1 is poorly expressed in liver, kidney, lung, and heart (27), and mouse PS-1 is poorly expressed in skeletal muscle and spleen. 2 We also reported that the PS-1 promoter was more active in cells differentiated to become neurons than in cells differentiated to a muscle phenotype (28). These differences suggest both cell type-specific and species-specific distributions of PS-1 expression. The brain, however, is the only organ where PS-1 is universally well expressed in human, rat, and mouse species. Using in situ hybridization, PS-1 mRNA is most highly expressed in neurons and below the limit of detection in other brain cells (29,30). These results strongly suggest the existence of a mechanism where PS-1 transcription is regulated in a neuron-specific manner in the brain.To understand presenilin-1 function, one of our approaches is to study regulatory mechanisms in the brain. PS-1 expression is higher in the hippocampus and cerebellum than in the cerebral cortex (29 -32). Hippocampal pyramidal neurons, dentate granule neurons, cerebellar Purkinje neurons, and primary olfactory cortical neurons show higher PS-1 expression than the neurons in other cortical regions of rat brain (33,34). Compared with the adult, the level of PS-1 expression is significantly higher in the developing rat brain. Peaking at postnatal day 10, PS-1 expression in the hippocampus and cerebellum is greatest at a time when proliferation, migration, and synapse formation are actively being completed (35).